Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-003465

EVP, Research & CSO sold 3,805 shares at $29.36 ($111,696)

  • EVP, Research & CSO acquired 3,805 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-01-12 Option exercise +3,805 $1.53 $5,822 37,005 D: show line 1 in the form
Virgin Herbert EVP, Research & CSO 2021-01-12 Sale −3,805 $29.36 $111,696 33,200 D: show line 2 in the form
Open-market sales · 3,805 sh · avg $29.36 · $111,696

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-01-12 Option exercise · Stock Option (Right to Buy) −3,805 421,985 D: show line 3 in the form
Loading xslF345X03/doc4.xml…